Cargando…
A Systematic Review of Parkinson’s Disease Pharmacogenomics: Is There Time for Translation into the Clinics?
Background: Parkinson’s disease (PD) is the second most frequent neurodegenerative disease, which creates a significant public health burden. There is a challenge for the optimization of therapies since patients not only respond differently to current treatment options but also develop different sid...
Autores principales: | Vuletić, Vladimira, Rački, Valentino, Papić, Eliša, Peterlin, Borut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268929/ https://www.ncbi.nlm.nih.gov/pubmed/34281267 http://dx.doi.org/10.3390/ijms22137213 |
Ejemplares similares
-
The effects of microbiota abundance on symptom severity in Parkinson’s disease: A systematic review
por: Papić, Eliša, et al.
Publicado: (2022) -
Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson’s disease and monogenic dystonia: a multidisciplinary team perspective
por: Rački, Valentino, et al.
Publicado: (2023) -
Cognitive Impact of Deep Brain Stimulation in Parkinson’s Disease Patients: A Systematic Review
por: Rački, Valentino, et al.
Publicado: (2022) -
Effect of the coronavirus disease 2019 pandemic on people with Parkinson's disease: experience from a Croatian regional center
por: Hero, Mario, et al.
Publicado: (2022) -
A multicenter study of genetic testing for Parkinson’s disease in the clinical setting
por: Kovanda, Anja, et al.
Publicado: (2022)